In 1974, New York physician Dr. Lum reported that serum GGT was several times the upper limit of normal in patients with biopsy‐confirmed metastatic hepatocellular carcinoma, pancreatic carcinoma, and gallbladder cancer. This evidence concerns the gene GGT1 and exocrine pancreatic carcinoma.